A. Fusco

Journal of Clinical Endocrinology and Metabolism · 2002–2007

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom A. Fusco trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. C. Bogdan
  2. M. Huber

Papers from A. Fusco's perspective

Ordered by how strongly the researchers A. Fusco trusts endorse each paper. Same corpus, a different order for every researcher.

  1. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. (Cell)
  2. A microRNA expression signature of human solid tumors defines cancer gene targets (Proceedings of the National Academy of Sciences of the United States of America)
  3. Molecular requirements for epithelial-mesenchymal transition during tumor progression. (Current Opinion in Cell Biology)
  4. Mutations of the BRAF gene in human cancer (Nature)
  5. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. (New England Journal of Medicine)
  6. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. (Science)
  7. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. (Cancer Research)
  8. BRAF mutation in papillary thyroid carcinoma. (Journal of the National Cancer Institute)
  9. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status (Nature)
  10. The multiple roles of PTEN in tumor suppression. (Cell)

Their papers